I would say watch this space. I presume after Phase II is finished (a and b) they will analyze the results for treatment vs prevention and decide which one to instigate another trial on first. This could be a trial like Takeda are doing (on a vaccination on a population in Brazil) but maybe somewhere in Asia (closer and a big Dengue area, no trials currently) or ??? Who knows and who knows what the cost will be at this point because getting a trial up in a lot of the lower socio-economic areas that are closer to the equator I assume should be cheaper than a large scale trial in other areas.
Just speculation. All I am saying is this is a question I think the board need to address once they know what they have.
ILA Price at posting:
18.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)